Economics of Pharmacogenomics: Rethinking Beyond QALYs?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|11|3|187-195

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.11, Iss.3, 2013-09, pp. : 187-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economics of Pharmacogenomics

By  

Current Pharmacogenomics, Vol. 1, Iss. 4, 2003-12 ,pp. : 277-284

Bentham Science Publishers

Access to resources Recommend Favorite

Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 4, 2012-12 ,pp. : 277-287

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 3, 2017-04 ,pp. : 221-230

Bentham Science Publishers

Access to resources Recommend Favorite

QALYs and Carers

By Al-Janabi Hareth  

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1015-1023

Adis International

Access to resources Recommend Favorite

The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics

By Cook Joseph  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite